ACE2 and COVID-19: Endothelial cells are known to be susceptible to SARS-CoV-2, and the roles of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) are key to understanding the vascular complications of COVID-19.